Universal Time: 05:23  |  Local Time: 05:23 (0h GMT)
Select your timezone:
Reset
Wed Oct 20 Thu Oct 21 Fri Oct 22 Sat Oct 23

DAY 1 - Pre-Congress Workshop on COVID-19
Diabetes and Transplantation - Understanding the Links

12:00 - 12:05 Introduction and Welcome
12:05 - 12:35 Diabetes, obesity, metabolism, and SARS-CoV-2 infection: What is true, what is false and what is uncertain
Daniel J. Drucker, Canada
Diabetes, Obesity, Metabolism and SARS-CoV2 Infection: What is true, what is false and what is uncertain
12:35 - 13:00 COVID-19 vaccine development: Types of vaccines and (preliminary) differences in efficacy in solid organ transplant recipients
Michael G. Ison, United States
COVID-19 vaccine development and preliminary efficacy in solid organ transplant recipients
13:10 - 13:55 Pancreas and Islet Transplantation in the Era of COVID-19 (Part 1)
Nikole A. Neidlinger, United States
Panelist
Marcelo Perosa MD, Brazil
Panelist
Duck-Jong Han, Korea
Panelist
Deepali Kumar, Canada
Panelist
13:55 - 14:20 Stem cell and exosome therapy for COVID-19
Camillo Ricordi, United States
Stem cell and exosome therapy for COVID-19
14:25 - 15:05 Best Covid Abstracts Session
Angelika C. Gruessner, United States
Impact of COVID-19 on pancreas transplantation – A Registry Analysis
Claire Counter, United Kingdom
Pancreas and islet transplantation in the UK during the COVID-19 era
Caterina Di Bella, Italy
Analysis of autoimmune re-activation after Covid-19 mRNA vaccination in pancreas transplant recipients
Cyril P. Landstra, Netherlands
Impact of the COVID-19 lockdown on behavior, stress, anxiety and glycemic control in patients with beta cell transplantation
15:05 - 15:50 Pancreas and Islet Transplantation in the Era of COVID-19 (Part 2)
Michael G. Ison, United States
Panelist
Aiko P.J. de Vries, Netherlands
Panelist
Jacqueline M. Garonzik Wang, United States
Panelist
16:00 - 16:25 Immunomodulatory Therapies for COVID-19: Lesson for/from Organ Transplantation
Lorenzo Piemonti, Italy
Targeting cytokines/chemokines
16:25 - 16:50 Stem Cell Model for Covid-19
Shuibing Chen, United States
Stem Cell Model for Covid-19
16:50 - 17:00 Final Remarks and Announcements